Zealand Pharma taps Centerview to explore partnership deals
Danish biotech firm Zealand Pharma A/S has picked Centerview Partners to help advise on potential partnerships as dealmaking by large drugmakers heats up, sources say.
By Dinesh Nair and Manuel Baigorri, bloomberg
Zealand Pharma is working with investment bank Centerview Partners to identify potential partners for a key rare disease treatment targeting short bowel syndrome, as well as for some dasiglucagon-based medications, people familiar with the matter said. The process may end up leading to a full sale of the company, which has previously been studied by large pharmaceutical firms, they said.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Zealand Pharma CEO has high hopes for obesity candidate
For subscribers
